of commercially insured patients nationwide have coverage for
VUMERITY.1 Download these materials to learn how to get started.
In the event you need to obtain approval or appeal a denial for VUMERITY, the following
sample letters are available to support communication with your patient’s health plan.
Biogen Support Services has financial and insurance assistance options that can help patients manage their VUMERITY cost, depending on their individual needs. If they are commercially insured and eligible, the Biogen Copay Program could lower their cost of VUMERITY to as little as $0.b
For more information on the copay program, download the electronic brochure.
a67% of people taking VUMERITY paid $0 in Jan-March 2022, compared to only 13% of those taking a generic dimethyl fumarate.1
bThere is an annual cap on the amount of assistance that patients can receive over a 1-year period. Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, the VA/DoD, or any other federal plans are not eligible to enroll. Your patients are eligible to enroll in the Biogen Copay Program for as long as it is offered and they are treated with a Biogen relapsing MS medication.1
Help your patients get support
Your patients can call
1-800-456-2255 Monday-Friday from 8:30 AM to 8:00 PM ET.